Overview

Cognitive/Cerebrovascular Consequences of HTN Treatment

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Randomized trial of two antihypertensive drugs of known efficacy to investigate whether one has more favorable effects on brain blood flow and cognitive function.
Phase:
N/A
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Atenolol
Lisinopril